ロード中...
Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones
BACKGROUND: It is well accepted that the immune system efficiently contributes to positive outcomes of chemotherapeutic cancer treatment by activating immunogenic cell death (ICD). However, only a limited number of ICD-inducing compounds are well characterized at present; therefore, identification o...
保存先:
| 出版年: | J Inflamm (Lond) |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8194247/ https://ncbi.nlm.nih.gov/pubmed/34112202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12950-021-00289-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|